CFGS
WST icon

Concourse Financial Group Securities’s West Pharmaceutical WST Stock Holding History

Concourse Financial Group Securities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-200
Closed -$69.6K – 2102
2024
Q4 		$69.6K Buy
200
+1
+0.5% +$315 ﹤0.01% 1068
2024
Q3 		$59.7K Sell
199
-51
-20% -$15.6K ﹤0.01% 1119
2024
Q2 		$82.3K Buy
250
+6
+2% +$2.12K 0.01% 991
2024
Q1 		$96.6K Buy
244
+4
+2% +$1.48K 0.01% 926
2023
Q4 		$84.5K Buy
240
+8
+3% +$2.83K 0.01% 948
2023
Q3 		$87K Sell
232
-46
-17% -$17.8K 0.01% 900
2023
Q2 		$106K Buy
278
+14
+5% +$5K 0.01% 860
2023
Q1 		$91.5K Sell
264
-32
-11% -$9.35K 0.01% 894
2022
Q4 		$69.7K Sell
296
-2,264
-88% -$536K 0.01% 949
2022
Q3 		$630K Sell
2,560
-150
-6% -$45.7K 0.06% 308
2022
Q2 		$819K Sell
2,710
-902
-25% -$294K 0.07% 286
2022
Q1 		$1.48M Sell
3,612
-207
-5% -$81K 0.11% 186
2021
Q4 		$1.79M Buy
3,819
+89
+2% +$38.3K 0.1% 197
2021
Q3 		$1.58M Sell
3,730
-826
-18% -$348K 0.1% 210
2021
Q2 		$1.64M Buy
4,556
+412
+10% +$136K 0.1% 191
2021
Q1 		$1.17M Buy
4,144
+78
+2% +$22.3K 0.08% 223
2020
Q4 		$1.15M Buy
4,066
+185
+5% +$51.9K 0.09% 205
2020
Q3 		$1.07M Sell
3,881
-421
-10% -$111K 0.09% 184
2020
Q2 		$977K Buy
4,302
+425
+11% +$83.5K 0.09% 168
2020
Q1 		$590K Buy
3,877
+825
+27% +$127K 0.07% 225
2019
Q4 		$459K Buy
3,052
+1,912
+168% +$278K 0.05% 312
2019
Q3 		$162K Buy
1,140
+884
+345% +$122K 0.04% 334
2019
Q2 		$32K Buy
256
+21
+9% +$2.48K ﹤0.01% 1042
2019
Q1 		$25K Buy
235
+69
+42% +$7.18K ﹤0.01% 1183
2018
Q4 		$16K Sell
166
-16
-9% -$1.74K ﹤0.01% 1262
2018
Q3 		$22K Buy
+182
New +$20.4K 0.01% 830

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Concourse Financial Group Securities's WST Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 200 shares — an estimated $69.6K sold.

Concourse Financial Group Securities first reported a position in WST in Q3 2018 and held it in 26 quarters. The position peaked at $1.79M in Q4 2021. 714 funds tracked by Wall St. Rank hold WST as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 200 West Pharmaceutical shares in Q1 2025, an estimated $69.6K.
  • Concourse Financial Group Securities first reported a position in West Pharmaceutical in Q3 2018 and held it in 26 quarters.
  • Concourse Financial Group Securities's West Pharmaceutical position peaked at $1.79M in Q4 2021.
  • 714 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.